Michael McTague, Ph.D., is executive vice president at private equity firm Able Global Partners in New York.
Latest Articles
Healthcare
Michael McTague: How can anyone afford breakthrough medicines?
Healthcare
Michael McTague: The pharmaceutical giants leading the market-cap parade in 2025
Healthcare
Michael McTague: Watch out for these killer superbugs that resist today’s antibiotics
Healthcare
Michael McTague: Just how unhealthy are we?
Education
Michael McTague: The financial ramifications of dismantling the Dept. of Education
Healthcare
Why weight-loss drugs are the top target of Medicare price negotiations
Investing Strategies
Michael McTague: In 2025, the pharmaceutical industry is ripe for M&A
Personal Finance
Michael McTague: 5 key pharmaceutical trends that will carry into 2025
Healthcare
Roche shifts toward obesity medication
Russia’s tourism strategy lags as travel surges post-pandemic
Healthcare
Michael McTague: How can anyone afford breakthrough medicines?
Healthcare
Why weight-loss drugs are the top target of Medicare price negotiations
Healthcare
Michael McTague: Watch out for these killer superbugs that resist today’s antibiotics
Healthcare
Michael McTague: The pharmaceutical giants leading the market-cap parade in 2025
Investing Strategies
Michael McTague: In 2025, the pharmaceutical industry is ripe for M&A